Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length

Human Molecular Genetics

Volumn 9, Issue 2, 2000, Pages 267-274

  Irvine, Ryan A ^a   Ma, Han ^a   Yu, Mimi C ^a   Ross, Ronald K ^a   Stallcup, Michael R ^a   Coetzee, Gerhard A ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; MICROSATELLITE DNA; POLYGLUTAMINE; PROTEIN; PROTEIN P160; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EXON; EXPRESSION VECTOR; GENE ACTIVATION; GENETIC POLYMORPHISM; MALE INFERTILITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; TRANSACTIVATION;

ANIMALIA;

EID: 0033978514     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/9.2.267     Document Type: Article

References (60)

1. Mangelsdorf, D.I., Thummel, C., Beato, M., Herrlich, P., Schutz. G., Umesono K., Blumberg, B., Kastner, P., Mark, M., Chambon, P. and Evans, R.E. (1995) The nuclear receptor superfamily: the second decade. Cell, 83, 835-839.
2. Lindzey, J., Kumar, V.M., Grossman, M., Young, C. and Tindall, D.J. (1994) Molecular mechanisms of androgen action. Vitamins Horm., 49, 383-432.
3. Choong, C.S. and Wilson, E.M. (1998) Trinucleotide repeats in the human androgen receptor: a molecular basis for disease. Mol. Endocrinol., 21, 235-257.
4. Lubahn, D.B., Brown, T.R., Simental, J.A., Higgs, H.N., Migeon, C.J., Wilson, E.M. and French, F.S. (1989) Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity. Proc. Natl. Acad. Sci. USA, 86, 9534-9538.
5. La Spada, A.R., Wilson, E.M., Lubahn, D.B., Harding, A.E. and Fischbeck, K.H. (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature, 352, 77-79.
6. La Spada, A.R., Roling, D.B., Harding A.E., Warner, C.L., Spiegel, R., Hausmanowa-Petrusewicz, I., Yee, W.C. and Fischbeck, K.H. (1992) Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nature Genet., 2, 301-304.
7. Arbizu, T., Santamaria, J., Gomex, J.M., Quilez, A. and Serra, J.P. (1983) A family with adult spinal and bulbar muscular atrophy, X-linked inheritance and associated testicular failure. J. Neurol. Sci., 59, 371-382.
8. Nagashima, T., Seko, K., Hirose, K., Mannen, T., Yoshimura, S., Arima, R., Nagashima, K. and Morimatsu, Y. (1988) Familial bulbo-spinal muscular atrophy associated with testicular atrophy and sensory neuropathy (Kennedy-Alter-Sung syndrome). Autopsy case report of two brothers. J. Neurol. Sci., 87, 141-152.
9. Mahtre, A.N., Trifiro, M.A., Kaufman, M., Kazemi-Esfarjani, P., Figlewicz, D., Rouleau, G. and Pinsky, L. (1993) Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nature Genet., 5, 184-188.
10. Chamberlain, N.L., Driver, E.D. and Miesfeld, R.L. (1994) The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res., 22, 3181-3186.
11. Tut, T.G., Ghadessy, F.J., Trifiro, M.A., Pinsky, L. and Yong. E.L. (1997) Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. J. Clin. Endocrinol. Metab., 82, 3777-3782.
12. Yong, E.L., Ghadessy, F., Wang, Q., Mifsud, A. and Ng, S.C. (1998) Androgen receptor transactivation domain and control of spermatogenesis. Rev. Reprod., 3. 141-144.
13. Dowsing, A.T., Yong, E.L., Clark, M., McLachlan, R.I., de Kretser, D.M. and Trounson, A.O. (1999) Linkage between male infertility and trinucleotide repeat expansion in the androgen-receptor gene. Lancet, 354, 640-643.
14. n-expanded neuronopathies. Hum. Mol. Genet., 4, 523-527.
15. Ross, R.K., Pike, M.C., Coetzee, G.A., Reichardt, J.K.V., Yu, M.C., Feigelson, H., Stanczyk, F.Z., Kolonel, L.N. and Henderson, B.E. (1998) Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility. Cancer Res., 58, 4497-4504.
16. Kantoff, P., Giovannucci, E. and Brown, M. (1998) The androgen receptor CAG repeat polymorphism and its relationship to prostate cancer. Biochim. Biophys. Acta, 1378, C1-C5.
17. Irvine, R.A., Yu, M.C., Ross, R.K. and Coetzee, G.A. (1995) The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res., 55, 1937-1940.
18. Ingles, S.A., Ross, R.K., Yu, M.C., Irvine, R.A., La Pera, G., Haile, R.W. and Coetzee, G.A. (1997) Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J. Natl Cancer Inst., 89, 166-170.
19. Giovannucci, E., Stampfer, M.J., Krithivas, K., Brown, M., Dahl, D., Brufsky, A., Talcott, J., Hennekens, C.H. and Kantoff, P.W. (1997) The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc. Natl Acad. Sci. USA, 94, 3320-3323.
20. Stanford, J.L., Just, J.J., Gibbs, M., Wichlund, K.G., Neal, C.L., Blumenstein, B.A. and Ostrander, E.A. (1997) Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res., 57, 1194-1198.
21. Giovannucci, E., Platz, E.A., Stampfer, M.J., Chan, A., Krithivas, K., Kawachi, I., Willett, W.C. and Kantoff, P.W. (1999) The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia. Urology, 53, 121-125.
22. Giovannucci, E., Stampfer, M.J., Chan, A., Krithivas, K., Gann, P.H., Hennekens, C.H. and Kantoff, P.W. (1999) CAG repeat within the androgen receptor gene and incidence of surgery for benign prostatic hyperplasia in U.S. physicians. Prostate, 39, 130-134.
23. Jenster, G., van der Korput, H.A.G.M., van Vroonhoven, C., van der Kwast, T.H., Trapman, J. and Brinkmann, A.O. (1991) Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. Mol. Endocrinol., 5, 1396-1404.
24. Jenster, G., van der Korput, H.A.G.M., Trapman, J. and Brinkmann, A.O. (1995) Identification of two transcription activation units in the N-terminal domain of the human androgen receptor. J. Biol. Chem., 270, 7341-7346.
25. Chamberlain, N.L., Whitacre, D.C. and Miesfeld, R.L. (1996) Delineation of two distinct type 1 activation functions in the androgen receptor amino-terminal domain. J. Biol. Chem., 271, 26772-26778.
26. Daniclian, P.S., White, R., Lees, J.A. and Parker, M.G. (1992) Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J., 11, 1025-1033.
27. Moras, D. and Gronemeyer, H. (1998) The nuclear receptor ligand-binding domain: structure and function. Curr. Opin. Cell Biol., 10, 384-391.
28. Snoek, R., Bruchovsky, N., Kasper, S., Matusik, R.J., Gleave, M., Sato, N., Mawji, N.R. and Rennie, P.S. (1988) Differential transactivation by the androgen receptor in prostate cancer cells. Prostate, 36, 256-263.
29. Torchia, J., Glass, C. and Rosenfeld, M.G. (1998) Co-activators and co-repressors in the integration of transcriptional responses. Curr. Opin. Cell Biol., 10, 373-383.
30. Xu, L., Glass, C. and Rosenfeld, M.G. (1999) Coactivator and corepressor complexes in nuclear receptor function. Curr. Opin. Genet. Dev., 9, 140-147.
31. Heery, D.M., Kalkhoven, E., Hoare, S. and Parker, M.G. (1997) A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature, 387, 733-736.
32. Torchia, J., Rose, D.W., Inostroza, J., Kamei, Y., Westin, S., Glass, C.K. and Rosenfeld, M.G. (1997) The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature, 387, 677-684.
33. Ding, X.F., Anderson, C.M., Ma, H., Hong, H., Uht, R.M., Kushner, P.J. and Stallcup, M.R. (1998) Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities. Mol. Endocrinol., 12, 302-313.
34. Chen, D., Ma, H., Hong, H., Koh, S.S., Huang, S.-M., Schurter, B.T., Aswad, D.W. and Stallcup, M.R. (1999) Regulation of transcription by a protein methyltransferase. Science, 284, 2174-2177.
35. Webb, P., Nguyen, P., Shinsako, J., Anderson, C., Feng, W., Nguyen, M.P., Chen, D., Huang, S.-M., Subramanian, S., McKinerney, E. et al. (1998) Estrogen receptor activation function 1 works by binding p160 coactivator proteins. Mol. Endocrinol., 12, 1605-1618.
36. Lavinsky, R.M., Jepsen, K., Heinzel, T., Torchia, J., Mullen, T.-M., Schiff, R., Del-Rio, A.L., Ricote, M., Ngo, S., Gemsch, J. et al. (1998) Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc. Natl Acad. Sci. USA, 95, 2920-2925.
37. Onate, S.A., Boonyaratanakornkit, V., Spencer, T.E., Tsai, S.Y., Tsai, M.-J., Edwards, D.P. and O'Malley, B. (1998) The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors. J. Biol. Chem., 273, 12101-12108.
38. Ma, H., Hong, H., Huang, S.-M., Irvine, R.A., Webb, P., Kushner, P.J., Coetzee, G.A. and Stallcup, M.R. (1999) Multiple signal input and output domains of the 160-kDa nuclear receptor coactivator proteins. Mol. Cell. Biol., 19, 6164-6173.
39. McInerney, E.M., Tsai, M.-J., O'Malley, B.W. and Katzenellenbogen, B.S. (1996) Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator. Proc. Natl Acad. Sci. USA, 93, 10069-10073.
40. Ikonen, T., Palvino, J.J. and Janne, O.A. (1997) Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators. J. Biol. Chem., 272, 29821-29828.
41. Gao, T., Marcelli, M. and McPaul, M.J. (1996) Transcriptional activation and transient expression of the human androgen receptor. J. Steroid Biochem. Mol. 59, 9-20.
42. Gast, A., Schneikert, J. and Cato, C.B. (1998) N-terminal sequences of the human androgen receptor in DNA binding and transrepressing functions. J. Steroid Biochem. Mol., 65, 117-123.
43. Langley, E., Zhou, Z. and Wilson, E. (1995) Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer. J. Biol. Chem., 270, 29983-29990.
44. Doesburg, P., Kuil, C.W., Berrevoets, C.A., Steketee, K., Faber, P.W., Mulder, E., Brinkmann, A.O. and Trapman, J. (1997) Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor. Biochemistry, 36, 1052-1064.
45. Berrevoets, C.A., Doesburg, P., Steketee, K., Trapman, J. and Brinkmann, A.O. (1998) Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2). Mol. Endocrinol., 12, 1172-1183.
46. Fronsdal, K., Engedal, N., Slagsvold, T. and Saatcioglu, F. (1998) CREB binding protein is a coactivator for the androgen receptor and mediates cross-talk with AP-1. J. Biol. Chem., 273, 31853-31859.
47. McEwan, I.J. and Gustafsson, J.-A. (1997) Interaction of the human androgen receptor transaclivation function with the general transcription factor TFIIF. Proc. Natl Acad. Sci. USA, 94, 8485-8490.
48. Choong, C.S., Kemppainen, J.A., Zhou, Z. and Wilson, E.M. (1996) Reduced androgen receptor gene expression with first exon CAG repeat expansion. Mol. Endocrinol., 10, 1527-1535.
49. Butler, R., Leigh, P.N., McPhaul, M.J. and Gallo, J.-M. (1998) Truncated forms of the androgen receptor are associated with polyglutamine expansion in X-linked spinal and bulbar muscular atrophy. Hum. Mol. Genet., 7, 121-127.
50. Stenoien, D.L., Cummings, C.J., Adams, H.P., Mancini, M.G., Kavita, P., Demartino, G.N., Marcelli, M., Weigel, N.L. and Mancini, M.A. (1999) Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. Hum. Mol. Genet., 8, 731-741.
51. Aarnisalo, P., Palvino, J.J. and Janne, O.A. (1998) CREB-binding protein in androgen receptor-mediated signaling. Proc. Natl Acad. Sci. USA, 95, 2122-2127.
52. Bischoff, F.R. and Ponstingl, H. (1991) Mitotic regulator protein RCC1 is complexed with a nuclear ras-related polypeptide. Proc. Natl Acad. Sci. USA, 88, 10830-10834.
53. Hsiao, P.-W., Lin, D.-L., Nakao, R. and Chang, C. (1999) The linkage of Kennedy's neuron disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivator. J. Biol. Chem., 274, 20229-20234.
54. Gerber, H.-P., Seipel, K., Georgiev, O., Hofferer, M., Hug, M., Rusconi, S. and Schaffner, W. (1994) Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science, 263, 808-811.
55. Anzick, S.L., Kononen, J., Walker, R.L., Azorsa, D.O., Tanner, M.M., Guan, X.-Y., Sauter, G., Kallioniemi, O.-P., Trent, J.M. and Meltzer, P.S. (1997) AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science, 277, 965-968.
56. Giguere, V., Hollenberg, S.M. and Evans, R.M. (1986) Functional domains of the human glucocorticoid receptor. Cell, 46, 645-652.
57. Schiestl, R.H. and Gietz, R.D. (1989) High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier. Curr. Genet., 16, 339-346.
58. Hill, J., Donald, K.A.I.G. and Griffiths, D.E. (1991) DMSO-enhanced whole cell yeast transformation. Nucleic Acids Res., 19, 5791.
59. Gietz, D., St Jean, A., Woods, R.A. and Schiestl, R.H. (1992) Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res., 20, 1425.
60. Ohnuki, Y., Marnell, M.M., Babcock, M.S., Lechner, J.F. and Kaighn M.E. (1980) Chromosomal analysis of human prostatic adenocarcinoma cell lines. Cancer Res., 40, 524-534.